Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular Thrombectomy
Conditions
Acute Ischemic Stroke
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Meizhou People's Hospital, Meizhou, Guangdong, China
Contact: Principal Investigator (Tongguo Wei)Luoyang Central Hospital, Luoyang, Henan, China
Contact: Principal Investigator (Zhihui Duan)Nanshi Hospital of Nanyang, Nanyang, Henan, China
Contact: Principal Investigator (Zhaolong Peng)Jilin Province People's Hospital, Changchun, Jilin, China
Contact: Principal Investigator (Zongshu Li)Meihe Hospital the First Hospital of Jilin University, Meihekou, Jilin, China
Contact: Principal Investigator (Rui Wang)Benxi Central Hospital, Benxi, Liaoning, China
Contact: Principal Investigator (Chengguang Song)General Hospital of Fuxin Mining Industry Group of Liaoning Health Industry Group, Fuxin, Liaoning, China
Contact: Principal Investigator (Lianqun Fu)Central Hospital Affiliated to Shenyang Medical College, Shengyang, Liaoning, China
Contact: Principal Investigator (Runhui Li)General Hospital of Northern Theater Command, Shenyang, Liaoning, China
Contact: Principal Investigator (Huisheng Chen)Linyi People's Hospital, Linyi, Shandong, China
Contact: Principal Investigator (Ziran Wang)Weifang People's Hospital, Weifang, Shandong, China
Contact: Principal Investigator (Li Zhou)Huashan Hospital Fudan University, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Xin Cheng)Contact: Principal Investigator (Liang Chen)Contact: Principal Investigator (Jing Zhang)Shanghai Tenth People's Hospital, Shanghai, Shanghai Municipality, China
Contact: Principal Investigator (Jianliang Fu)Linfen Central Hospital, Linfen, Shanxi, China
Contact: Principal Investigator (Hongguo Dai)